prenatal testing
Craig-Hallum Initiates Coverage of Myriad Genetics With a Buy Rating
Craig-Hallum expects stable Prolaris revenues and sees opportunities for significant growth in the hereditary cancer and prenatal testing markets.
BillionToOne Raises $130M in Series D Financing Round
The Menlo Park, California-based company will use the funds to expand and scale its prenatal and oncology testing businesses.
Natera Reports 52 Percent Spike in Q1 Revenues, Raises Full-Year Guidance
The company beat analysts' estimates on the top and bottom lines with growth driven by increased testing volumes and improvements in average test selling price.
Myriad Genetics Q4, Full-Year Revenues Jump 11 Percent on Strong Test Volume Growth
For the three months ended Dec. 31 Myriad reported $196.6 million in revenues compared to $177.8 million for the same quarter in 2022, beating analysts' average estimate.
ACMG Asserts Evidence Insufficient for Clinical Utility of Polygenic Risk Scores for Embryo Testing
Premium
The risk of harm to prospective parents or future children outweighs the benefits of preimplantation genetic testing, an ACMG working group said.
Apr 27, 2023
Sep 1, 2022
Apr 14, 2021
Jun 15, 2020
Yourgene Health Gets CE Mark for Iona NIPT Test
May 1, 2020
Nov 8, 2019
Sep 13, 2019